Avicanna Inc.

TSE: AVCN


Canadian symbol: AVCN.TO
US symbol: AVCNF

Currency in CAD

Valuation Measures

Market Cap (intraday) 529.53M
Enterprise Value 343.56M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)26.90
Price/Book (mrq)1.59
Enterprise Value/Revenue 339.67
Enterprise Value/EBITDA 6-2.16

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-73.49%
S&P500 52-Week Change 312.20%
52 Week High 34.3100
52 Week Low 30.6600
50-Day Moving Average 31.3803
200-Day Moving Average 31.4420

Share Statistics

Avg Vol (3 month) 332.82k
Avg Vol (10 day) 342.44k
Shares Outstanding 528.34M
Float 19.16M
% Held by Insiders 138.31%
% Held by Institutions 10.00%
Shares Short (Aug. 30, 2020) 419.03k
Short Ratio (Aug. 30, 2020) 40.46
Short % of Float (Aug. 30, 2020) 4N/A
Short % of Shares Outstanding (Aug. 30, 2020) 40.08%
Shares Short (prior month Jul. 30, 2020) 418.8k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2019
Most Recent Quarter (mrq)Jun. 29, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,954.31%

Management Effectiveness

Return on Assets (ttm)-29.79%
Return on Equity (ttm)-67.81%

Income Statement

Revenue (ttm)1.1M
Revenue Per Share (ttm)0.05
Quarterly Revenue Growth (yoy)4,181.40%
Gross Profit (ttm)92.14k
EBITDA -20.17M
Net Income Avi to Common (ttm)-22.39M
Diluted EPS (ttm)-0.9400
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)81.7k
Total Cash Per Share (mrq)0
Total Debt (mrq)3.46M
Total Debt/Equity (mrq)12.65
Current Ratio (mrq)0.73
Book Value Per Share (mrq)0.69

Cash Flow Statement

Operating Cash Flow (ttm)-15.56M
Levered Free Cash Flow (ttm)-12.98M

mrq = Most Recent Quarter
ttm = Trailing Twelve Months
yoy = Year Over Year
lfy = Last Fiscal Year
fye = Fiscal Year Ending
fy = Forward Year
Shares outstanding is taken from the most recently filed quarterly or annual report and Market Cap is calculated using shares outstanding.

Fundamentals are updated every day.
Full screen




Cannabis Market and Business News

Real-time cannabis business news from hundreds of sources. Never miss the news that matters the most.




Company News Date
AVCN.TO
Avicanna
3 weeks ago
AVCN.TO
Avicanna
1 month ago
AVCN.TO
Avicanna
3 months ago
AVCN.TO
Avicanna
4 months ago
AVCN.TO
Avicanna
4 months ago
AVCN.TO
Avicanna
4 months ago
AVCN.TO
Avicanna
5 months ago
AVCN.TO
Avicanna
5 months ago
AVCN.TO
Avicanna
8 months ago
AVCN.TO
Avicanna
8 months ago
AVCN.TO
Avicanna
9 months ago
AVCN.TO
Avicanna
9 months ago
AVCN.TO
Avicanna
10 months ago
AVCN.TO
Avicanna
10 months ago
AVCN.TO
Avicanna
11 months ago
AVCN.TO
Avicanna
11 months ago
AVCN.TO
Avicanna
1 year ago
AVCN.TO
Avicanna
1 year ago
AVCN.TO
Avicanna
1 year ago

Currency in CAD
Earnings EstimateCurrent Qtr. (Sep 2020)Next Qtr. (Dec 2020)Current Year (2020)Next Year (2021)
No. of Analysts0000
Avg. Estimate0000
Low Estimate0000
High Estimate0000
Year Ago EPSN/A-0.34N/AN/A
Revenue EstimateCurrent Qtr. (Sep 2020)Next Qtr. (Dec 2020)Current Year (2020)Next Year (2021)
No. of Analysts1111
Avg. Estimate1M1.3M3.2M10.3M
Low Estimate1M1.3M3.2M10.3M
High Estimate1M1.3M3.2M10.3M
Year Ago SalesN/A123k168k3.2M
Sales Growth (year/est)N/A956.90%1,804.80%221.90%
Earnings HistoryInvalid Date2019-12-302020-03-302020-06-29
EPS Est.N/A-0.15-0.09-0.26
EPS ActualN/A-0.34-0.11-0.23
DifferenceN/A-0.19-0.020.03
Surprise %N/A-126.70%-22.20%11.50%
EPS TrendCurrent Qtr. (Sep 2020)Next Qtr. (Dec 2020)Current Year (2020)Next Year (2021)
Current Estimate0000
7 Days Ago-0.2-0.15-0.7-0.23
30 Days Ago-0.2-0.15-0.7-0.23
60 Days Ago-0.2-0.15-0.7-0.23
90 Days Ago-0.2-0.15-0.7-0.23
EPS RevisionsCurrent Qtr. (Sep 2020)Next Qtr. (Dec 2020)Current Year (2020)Next Year (2021)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesAVCN.TOIndustrySector(s)S&P 500
Current Qtr.N/AN/AN/AN/A
Next Qtr.N/AN/AN/AN/A
Current YearN/AN/AN/AN/A
Next YearN/AN/AN/AN/A
Next 5 Years (per annum)N/AN/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A


Insiders transactions are updated every hour.

Major Holders

Currency in CAD
Breakdown
38.31%% of Shares Held by All Insider
0.00%% of Shares Held by Institutions
0.00%% of Float Held by Institutions
0Number of Institutions Holding Shares
Coming Soon

Search SEDAR Filings

Company Name:
Document Type:
Start Date:
End Date:

Press Releases by Avicanna Inc.


Avicanna's subsidiary obtains GPP certification and authorization by INVIMA for the compounding and sale of pharmaceutical cannabinoid products with medical prescriptions in Colombia

Avicanna’s subsidiary obtains GPP certification and authorization by INVIMA for the compounding and sale of pharmaceutical cannabinoid products with medical prescriptions in Colombia

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS/Authorized cannabinoid products will be available to the medical community and patients in early Q4 2020 including Avicanna's advanced o... Read More...
Avicanna Advances its Supply Chain Business and Announces Filing of Amended Interim Financial Statements

Avicanna Advances its Supply Chain Business and Announces Filing of Amended Interim Financial Statements

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS/TORONTO, Sept. 4, 2020 - Avicanna Inc. ("Avicanna" or the "Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company fo... Read More...
MediPharm Labs Launches New Sublingual Sprays for Sale via Medical Cannabis by Shoppers™ Under Agreement With Avicanna

MediPharm Labs Launches New Sublingual Sprays for Sale via Medical Cannabis by Shoppers™ Under Agreement With Avicanna

BARRIE, Ontario, Aug. 26, 2020 -- MediPharm Labs Corp., (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, today announced its wholly-owned subsidiary, MediPharm Labs Inc., has launched a... Read More...
Avicanna Advances its Supply Chain Business with Commercial Exports of CBG And CBD into the United States and Germany as well as Industrial Scale THC Quota Granted by the Colombian Authorities

Avicanna Advances its Supply Chain Business with Commercial Exports of CBG And CBD into the United States and Germany as well as Industrial Scale THC Quota Granted by the Colombian Authorities

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS/ The export of the CBG isolates into the United States is part of the first known industrial cultivation, extraction, and purification... Read More...
Avicanna Reports Second Quarter 2020 Financial Results and Provides Corporate Update

Avicanna Reports Second Quarter 2020 Financial Results and Provides Corporate Update

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS/Successfully launched advanced "medical cannabis 2.0" products under RHO Phyto™ brand nation-wide in Canada through Medical Cannabis by ... Read More...
Avicanna and Red White & Bloom Enter Exclusive Partnership for the Distribution and Commercialization of Pura H&W Hemp-Derived CBD-Based Topical Products in the United States

Avicanna and Red White & Bloom Enter Exclusive Partnership for the Distribution and Commercialization of Pura H&W Hemp-Derived CBD-Based Topical Products in the United States

The partnership allows for both companies to stake a claim in the expanding $532 billion beauty industry with the most advanced and only clinically backed CBD skin care line/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLAT... Read More...
Red White & Bloom and Avicanna enter into exclusive partnership for the distribution and commercialization of Pura H&W CBD-based Topical Products in the United States

Red White & Bloom and Avicanna enter into exclusive partnership for the distribution and commercialization of Pura H&W CBD-based Topical Products in the United States

Pura H&W ProductsPura H&W ProductsPura H&W ProductsPartnership allows for both companies to stake a claim in the expanding $532 billion beauty industry with the most advanced and only clinically backed CBD skin care line;Product line synergistically combines natural ingredients with CBD in advanced and proprietary formulations... Read More...
1) Cannabinoid-based pharmaceutical formulations for the treatment of COVID-19 in collaboration with the University of Toronto; and, 2) Evaluation of cannabinoids for reversing cannabis-based toxicosis in collaboration with the University of Guelph

1) Cannabinoid-based pharmaceutical formulations for the treatment of COVID-19 in collaboration with the University of Toronto; and, 2) Evaluation of cannabinoids for reversing cannabis-based toxicosis in collaboration with the University of Guelph

In addition to a recent MITACS award, Dr. Christine Allen, a Professor at the University of Toronto, was awarded an NSERC Alliance grant for development of cannabinoid-based pharmaceutical formulations for the treatment of COVID-19 induced lung inflammation Avicanna further expands its existing neurobiological research collaboration with ... Read More...
Avicanna Announces Participation in a Medical Cannabis Real-World Evidence (MC-RWE) Research Study Led by the University Health Network in Partnership with Medical Cannabis by Shoppers™ using its Rho Phyto™ Advanced Medical Cannabis Formulary of Products

Avicanna Announces Participation in a Medical Cannabis Real-World Evidence (MC-RWE) Research Study Led by the University Health Network in Partnership with Medical Cannabis by Shoppers™ using its Rho Phyto™ Advanced Medical Cannabis Formulary of Products

The Rho Phyto portfolio contains a full formulary of products including oil drops, sublingual sprays, capsules, and topicals that have controlled dosing, enhanced absorption and stability studies supported by pre-clinical data which will be available exclusively on the Medical Cannabis by Shoppers™ online portal by the end of July 2020 .T... Read More...
Avicanna Announces Co-development of a Cannabinoid-based Formulation for Treatment of COVID-19 related Lung Inflammation with Support from the Mitacs Accelerate Program

Avicanna Announces Co-development of a Cannabinoid-based Formulation for Treatment of COVID-19 related Lung Inflammation with Support from the Mitacs Accelerate Program

Avicanna further expands its existing research collaboration with Dr. Christine Allen's Research Group at the University of Toronto to include the development of a cannabinoid-based pharmaceutical for the treatment of COVID-19 induced lung inflammationThis project proposal has been peer-reviewed and has successfully obtained funding from ... Read More...
Avicanna to Host Virtual Symposium Titled "Medical Cannabis 2.0" on July 21st, 2020 in Partnership with Medical Cannabis By Shoppers™ in Anticipation of the Launch of its Rho Phyto™ Product Line

Avicanna to Host Virtual Symposium Titled “Medical Cannabis 2.0” on July 21st, 2020 in Partnership with Medical Cannabis By Shoppers™ in Anticipation of the Launch of its Rho Phyto™ Product Line

- - -The symposium will present the evolution of medical cannabis including the Avicanna-led advancements in R&D for novel cannabinoid delivery forms and formulations in addition to enhanced access for patients by Medical Cannabis by Shoppers. - - - This year's annual symposium coincides with the expected launch of Avicanna's RHO Phyt... Read More...
Avicanna Completes First Ever Export of Feminized Hemp Seeds For Cultivation Use to the United States and Closes the Initial Sale

Avicanna Completes First Ever Export of Feminized Hemp Seeds For Cultivation Use to the United States and Closes the Initial Sale

Seven million CBG dominant feminized seeds have been successfully exported to the US from Colombia and an additional seventy-five million seeds remain in inventory for sale to international markets.The successful export marks the commencement of revenue generation from Avicanna's seed business unit and another validation of it's diversifi... Read More...
Avicanna Successfully Registers the First Group of its Pura Earth™ CBD-Based Derma-Cosmetic Product Line in the European Union in Preparation for its Commercialization

Avicanna Successfully Registers the First Group of its Pura Earth™ CBD-Based Derma-Cosmetic Product Line in the European Union in Preparation for its Commercialization

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES . ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS/The initial registration is the final step in authorization of the brand's launch of the full suite of 9 products which will be permitt... Read More...
Avicanna Reports First Quarter 2020 Financial Results and Provides Corporate Update

Avicanna Reports First Quarter 2020 Financial Results and Provides Corporate Update

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS/ TORONTO, May 25, 2020 - Avicanna Inc. ("Avicanna" or the "Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company f... Read More...
Avicanna to Postpone Reporting First Quarter 2020 Results Due to Delays Caused by COVID-19

Avicanna to Postpone Reporting First Quarter 2020 Results Due to Delays Caused by COVID-19

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS./ TORONTO, May 14, 2020 - Avicanna Inc. ("Avicanna" or the "Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) announces that due to logisti... Read More...
Avicanna Signs Wide-Ranging Strategic Manufacturing and IP Licensing Agreement with World-Class Canadian Manufacturer MediPharm Labs

Avicanna Signs Wide-Ranging Strategic Manufacturing and IP Licensing Agreement with World-Class Canadian Manufacturer MediPharm Labs

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES . ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS/TORONTO , May 14, 2020 - Avicanna Inc. ("Avicanna" or the "Company") (AVCN.TO) (AVCNF) (0NN.F), a biopharmaceutical company focused on ... Read More...
Avicanna Receives Government Support and Approval for First Ever Export of Hemp Seeds From Colombia

Avicanna Receives Government Support and Approval for First Ever Export of Hemp Seeds From Colombia

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS/ TORONTO, May 7, 2020 - Avicanna Inc. ("Avicanna" or the "Company") (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company ... Read More...
Avicanna Closes Non-Brokered Private Placement with Group of Strategic Investors and Announces Warrant Re-Pricing

Avicanna Closes Non-Brokered Private Placement with Group of Strategic Investors and Announces Warrant Re-Pricing

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES . ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS/TORONTO , April 21, 2020 - Avicanna Inc. ("Avicanna" or the "Company) (AVCN.TO) (AVCNF) (0NN.F), a biopharmaceutical company focused on... Read More...
Avicanna Reports Fourth Quarter 2019 Financial Results and Provides Corporate Update

Avicanna Reports Fourth Quarter 2019 Financial Results and Provides Corporate Update

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES . ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS/TORONTO , April 15, 2020 - Avicanna Inc. ("Avicanna" or the "Company) (AVCN.TO) (AVCNF) (0NN.F) a biopharmaceutical company focused on ... Read More...
Avicanna to Postpone Reporting Fourth Quarter and Full Year 2019 Results Due to Delays Caused by COVID-19

Avicanna to Postpone Reporting Fourth Quarter and Full Year 2019 Results Due to Delays Caused by COVID-19

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES . ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS./TORONTO , March 30, 2020 - Avicanna Inc. ("Avicanna" or the "Company) (AVCN.TO) (AVCNF) (0NN.F) announces that due to logistics and de... Read More...
Avicanna to Supply Australian Market with Cannabis-Based Medicinal Products Through Distribution Agreement with Cannvalate

Avicanna to Supply Australian Market with Cannabis-Based Medicinal Products Through Distribution Agreement with Cannvalate

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES . ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS/TORONTO , Feb. 24, 2020 - Avicanna Inc. ("Avicanna" or the "Company") (AVCN.TO) (AVCNF) (0NN.F), a biopharmaceutical company focused on... Read More...
Avicanna Ranks Highest Amongst Global Cannabis Companies in the SAM Corporate Sustainability Assessment (CSA)

Avicanna Ranks Highest Amongst Global Cannabis Companies in the SAM Corporate Sustainability Assessment (CSA)

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES . ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS/TORONTO , Feb. 6, 2020 - Avicanna Inc. ("Avicanna" or the "Company") (AVCN.TO) (AVCNF) (0NN.F), a biopharmaceutical company focused on ... Read More...
Avicanna Closes First Tranche of Private Placement

Avicanna Closes First Tranche of Private Placement

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES . ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS/TORONTO , Jan. 24, 2020 - Avicanna Inc. ("Avicanna" or the "Company") (AVCN.TO) (AVCNF) (FSE:0NN), a biopharmaceutical company focused ... Read More...
Avicanna Announces the Successful Completion of its Clinical Study Evaluating the Effect of an Emollient Cream Containing 0.5% Cannabidiol on Skin Hydration

Avicanna Announces the Successful Completion of its Clinical Study Evaluating the Effect of an Emollient Cream Containing 0.5% Cannabidiol on Skin Hydration

- - -Expects to present additional data from this study at future medical conferences and publications- - -This completed study is the first known completed derma-cosmetic study on cannabinoids - - -Plans to announce data from additional clinical studies of two other proprietary formulas used for Pura Earth products in Q1 2020/NOT FOR DIS... Read More...
Avicanna Announces Agreement with Medical Cannabis by Shoppers, a Subsidiary of Shoppers Drug Mart Inc., to Distribute Avicanna's Advanced and Evidence-based Medical Cannabis and Derma-Cosmetic Products Across Canada

Avicanna Announces Agreement with Medical Cannabis by Shoppers, a Subsidiary of Shoppers Drug Mart Inc., to Distribute Avicanna’s Advanced and Evidence-based Medical Cannabis and Derma-Cosmetic Products Across Canada

Rho Phyto medical cannabis products and Pura Earth derma-cosmetics to be available exclusively in Canada online through Medical Cannabis by Shoppers in early-2020/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES . ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNI... Read More...
Avicanna to Host Key Opinion Leader Meeting on the Use of Cannabinoids for the Treatment of Pain and Epilepsy

Avicanna to Host Key Opinion Leader Meeting on the Use of Cannabinoids for the Treatment of Pain and Epilepsy

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES . ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS/Avicanna CEO, Aras Azadian , also to provide corporate update and pipeline overviewTORONTO , Dec. 6, 2019 - Avicanna Inc. ("Avicanna" o... Read More...
Avicanna to Supply UK Market with Cannabis-Based Medicinal Products Through Distribution Agreement with the LYPHE Group

Avicanna to Supply UK Market with Cannabis-Based Medicinal Products Through Distribution Agreement with the LYPHE Group

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS./ TORONTO, Dec. 3, 2019 - Avicanna Inc. ("Avicanna" or the "Company") (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company... Read More...
Avicanna Announces Voluntary Lock-Up Agreements for Key Insiders and Separation of CEO and Chairman Roles

Avicanna Announces Voluntary Lock-Up Agreements for Key Insiders and Separation of CEO and Chairman Roles

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS./ TORONTO, Oct. 29, 2019 - Avicanna Inc. ("Avicanna" or the "Company") (TSX: AVCN) (OTCQX: AVCNF), a biopharmaceutical company focused o... Read More...
Avicanna (TSX: AVCN) Completes First Commercial Exports of CBD to South Africa and the United Kingdom

Avicanna (TSX: AVCN) Completes First Commercial Exports of CBD to South Africa and the United Kingdom

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS/ TORONTO, Oct. 24, 2019 - Avicanna Inc. ("Avicanna" or the "Company") (TSX: AVCN)(OTCQX: AVCNF), a biopharmaceutical company focuse... Read More...
Avicanna Announces Retail Launch of Pura Earth Derma-Cosmetics with Initial Roll-Out in Colombia

Avicanna Announces Retail Launch of Pura Earth Derma-Cosmetics with Initial Roll-Out in Colombia

Pura Earth derma-cosmetics available in approximately 59 retail locations throughout Colombia, including Blind prestige beauty shops and Cromantic professional beauty markets /NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIO... Read More...
Avicanna (TSX: AVCN) Announces Receipt of the First Colombian USDA Organic Certification for its Hemp Cultivation and Registration of 15 Additional Genetics

Avicanna (TSX: AVCN) Announces Receipt of the First Colombian USDA Organic Certification for its Hemp Cultivation and Registration of 15 Additional Genetics

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS/ TORONTO, Oct. 18, 2019 - Avicanna Inc. ("Avicanna" or the "Company") (TSX: AVCN) (OTCQX: AVCNF), a biopharmaceutical company focus... Read More...
Avicanna (TSX: AVCN) Announces First Commercial Sale of the Pura Earth Derma-Cosmetics line of CBD Products

Avicanna (TSX: AVCN) Announces First Commercial Sale of the Pura Earth Derma-Cosmetics line of CBD Products

The sale was completed through Avicanna's wholly owned subsidiary, Avicanna LATAM S.A.S., to Percos S.A. ("Percos"), Avicanna's exclusive distributor of Pura Earth™ derma-cosmetics products in Colombia. The initial order from Percos included Avicanna's Anti-Aging Treatment, Anti-Aging Serum, Clear Skin Treatment and Intensive Skin C... Read More...
Avicanna (TSX: AVCN) to Open its Next Phase Extraction Facility in Colombia's Free Trade Zone

Avicanna (TSX: AVCN) to Open its Next Phase Extraction Facility in Colombia’s Free Trade Zone

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS/ TORONTO, Sept. 30, 2019 - Avicanna Inc. ("Avicanna" or the "Company") (TSX: AVCN), a biopharmaceutical company focused on the deve... Read More...
Avicanna (TSX: AVCN) Aras Azadian, CEO & Co-Founder to speak at the 12th Annual International Natural & Organic Cosmetics Conference About Organic CBD Skin Care and Pura Earth™ in Berlin, Germany

Avicanna (TSX: AVCN) Aras Azadian, CEO & Co-Founder to speak at the 12th Annual International Natural & Organic Cosmetics Conference About Organic CBD Skin Care and Pura Earth™ in Berlin, Germany

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS/ TORONTO, Sept. 23, 2019 /CNW/ - Avicanna Inc. ("Avicanna" or the "Company")(TSX: AVCN), a biopharmaceutical company focused on the... Read More...
Avicanna (TSX: AVCN) Enters an Exclusive Research Agreement with the University of Guelph for Proprietary Cannabinoid-based Products and Formulations to Treat Psychiatric Disorders

Avicanna (TSX: AVCN) Enters an Exclusive Research Agreement with the University of Guelph for Proprietary Cannabinoid-based Products and Formulations to Treat Psychiatric Disorders

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS./ TORONTO, Sept. 13, 2019 - Avicanna Inc. ("Avicanna" or the "Company") (TSX: AVCN), a biopharmaceutical company focused on the dev... Read More...
Avicanna (TSX: AVCN) Further Strengthens its Position as a Canadian Leader in Cannabinoid Based Research and Development with Expansion of University of Toronto Collaboration and Execution of University of Guelph Research Agreement

Avicanna (TSX: AVCN) Further Strengthens its Position as a Canadian Leader in Cannabinoid Based Research and Development with Expansion of University of Toronto Collaboration and Execution of University of Guelph Research Agreement

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES . ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS/TORONTO , Aug. 30, 2019 - Avicanna Inc. ("Avicanna" or the "Company") (TSX: AVCN) a biopharmaceutical company focused on the developmen... Read More...
AVCN) Further Strengthens its Position as a Canadian Leader in Cannabinoid Based Research and Development with Expansion of University of Toronto Collaboration and Execution of University of Guelph Research Agreement

AVCN) Further Strengthens its Position as a Canadian Leader in Cannabinoid Based Research and Development with Expansion of University of Toronto Collaboration and Execution of University of Guelph Research Agreement

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS/ TORONTO, Aug. 30, 2019 - Avicanna Inc. ("Avicanna" or the "Company") (TSX: AVCN) a biopharmaceutical company focused on the development... Read More...
Avicanna (TSX: AVCN) Completes its First Exportation of Cannabinoids from Colombia to Canada for Scientific Purposes

Avicanna (TSX: AVCN) Completes its First Exportation of Cannabinoids from Colombia to Canada for Scientific Purposes

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES . ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS/TORONTO , Aug. 23, 2019 - Avicanna Inc. ("Avicanna" or the "Company") (TSX: AVCN) a biopharmaceutical company focused on the developmen... Read More...
AVCN) Completes its First Exportation of Cannabinoids from Colombia to Canada for Scientific Purposes

AVCN) Completes its First Exportation of Cannabinoids from Colombia to Canada for Scientific Purposes

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS/ TORONTO, Aug. 23, 2019 - Avicanna Inc. ("Avicanna" or the "Company") (TSX: AVCN) a biopharmaceutical company focused on the developmen... Read More...
Avicanna Secures Canadian Cannabinoid Research Licence at its Headquarters in Toronto's Discovery District

Avicanna Secures Canadian Cannabinoid Research Licence at its Headquarters in Toronto’s Discovery District

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES . ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS/TORONTO , Aug. 19, 2019 - Avicanna Inc. ("Avicanna" or the "Company") a biopharmaceutical company focused on the development, manufactu... Read More...
Coming Soon.
SymbolExchangePriceChangeAs of
AVCN.TO
The Toronto Stock Exchange
The Toronto Stock Exchange1.10CAD--
0NN.F
Frankfurt Stock Exchange
Frankfurt Stock Exchange0.73EUR-1.62%
AVCNF.PK
OTC MARKETS GROUP L1 AND L2
OTC MARKETS GROUP L1 AND L20.85USD+2.41%
0NN.MU
Munich Stock Exchange
Munich Stock Exchange1.03EUR0.00%
0NN.BE
Berlin Stock Exchange
Berlin Stock Exchange0.72EUR-1.23%
AVCN.GO
Canadian Securities Exchange/PURE - CSE Listed & Other Canadian Listed Securities
Canadian Securities Exchange/PURE - CSE Listed & Other Canadian Listed Securities1.80CAD--
AVCNF.PQ
OTC MARKETS GROUP L1 AND L2
OTC MARKETS GROUP L1 AND L21.06USD--

Delayed data (1h)


Share this page